Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and Brian C. Pogue, PhD have mitigated by using common clinical technologies.
from The Medical News http://ift.tt/1Cg9ds2
from The Medical News http://ift.tt/1Cg9ds2
No comments:
Post a Comment